Morgan Stanley maintains MetLife (NYSE:MET) with a Overweight and raises the price target from $73 to $74.
Morgan Stanley Maintains Overweight on MetLife, Raises Price Target to $74
Morgan Stanley maintains MetLife (NYSE:MET) with a Overweight and raises the price target from $73 to $74.